PROCEPT BioRobotics (PRCT) Non-Current Assets (2020 - 2026)
PROCEPT BioRobotics' (PRCT) quarterly Non-Current Assets came in at $59.1 million in Q2 2026, up 7.42% year-over-year from $55.0 million in Q2 2025, and little changed quarter-over-quarter from $59.0 million in Q1 2026.
Analysis
PROCEPT BioRobotics (PRCT) Non-Current Assets (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Non-Current Assets for 7 consecutive years, with $59.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 7.42% year-over-year to $59.1 million in Q2 2026; TTM through Jun 2026 was $232.6 million, a 9.76% increase from a year earlier, with the FY2025 full-year figure at $57.7 million, up 10.6% from the prior year.
- Non-Current Assets was $59.1 million for Q2 2026 at PROCEPT BioRobotics, roughly flat from $59.0 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $59.1 million in Q2 2026 and troughed at $12.6 million in Q2 2022.
- A 5-year average of $46.4 million and a median of $52.5 million in 2023 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets jumped 238.25% in 2022 and retreated 3.65% in 2024, its largest moves.
- Over 5 years, Non-Current Assets stood at $36.7 million in 2022, then jumped by 47.54% to $54.2 million in 2023, then fell by 3.65% to $52.2 million in 2024, then rose by 10.6% to $57.7 million in 2025, then climbed by 2.36% to $59.1 million in 2026.
- The last three Non-Current Assets figures came in at $59.1 million (Q2 2026), $59.0 million (Q1 2026), and $57.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 8.29 Bn |
| 10 | PROCEPT BioRobotics | 1.17 Bn | 895.36 Mn | 62.38 Mn | 59.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.07 Mn |
| Mar 31, 2026 | 59.03 Mn |
| Dec 31, 2025 | 57.70 Mn |
| Sep 30, 2025 | 56.79 Mn |
| Jun 30, 2025 | 54.99 Mn |
| Mar 31, 2025 | 53.58 Mn |
| Dec 31, 2024 | 52.18 Mn |
| Sep 30, 2024 | 51.16 Mn |
| Jun 30, 2024 | 52.46 Mn |
| Mar 31, 2024 | 53.71 Mn |
| Dec 31, 2023 | 54.15 Mn |
| Sep 30, 2023 | 52.46 Mn |
| Jun 30, 2023 | 42.43 Mn |
| Mar 31, 2023 | 38.88 Mn |
| Dec 31, 2022 | 36.70 Mn |
| Sep 30, 2022 | 35.11 Mn |
| Jun 30, 2022 | 12.59 Mn |
| Mar 31, 2022 | 12.93 Mn |
| Dec 31, 2021 | 10.85 Mn |
| Sep 30, 2021 | 11.99 Mn |